| WARRANTS | 9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep. 30, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Warrants | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| STOCK WARRANTS | NOTE 7 – WARRANTS 
 The following table summarizes information with respect to outstanding warrants to purchase common stock of the Company at September 30, 2017: 
 
 
 During the nine months ended September 30, 2017, 2,250 warrants with an exercise price of $6.30 were exercised. During the nine months ended September 30, 2017, 33,089 warrants with an exercise price of $250.00 expired. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||